CBSCBS News·2hHealth
score-0.55
FDA Approval Gap Exposed as Brooklyn Bodega Sells Unapproved Weight-Loss Drug Retatrutide, Prompting Calls for Tighter Oversight
Original
What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug
“Uses sensationalist framing ('craze,' unauthorized sale) to emphasize regulatory concern and public health risk without balanced context.”